Literature DB >> 464094

Pancreatic alpha- and beta-cell responses to GIP infusion in normal man.

D Elahi, D K Andersen, J C Brown, H T Debas, R J Hershcopf, G S Raizes, J D Tobin, R Andres.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 464094     DOI： 10.1152/ajpendo.1979.237.2.E185

Source DB:  PubMed          Journal:  Am J Physiol        ISSN： 0002-9513


× No keyword cloud information.
  16 in total

Review 1.  Glucagon-Like Peptide-1 and Its Class B G Protein-Coupled Receptors: A Long March to Therapeutic Successes.

Authors:  Chris de Graaf; Dan Donnelly; Denise Wootten; Jesper Lau; Patrick M Sexton; Laurence J Miller; Jung-Mo Ahn; Jiayu Liao; Madeleine M Fletcher; Dehua Yang; Alastair J H Brown; Caihong Zhou; Jiejie Deng; Ming-Wei Wang
Journal:  Pharmacol Rev       Date:  2016-10       Impact factor: 25.468

Review 2.  Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass.

Authors:  Yunfeng Cui; Dariush Elahi; Dana K Andersen
Journal:  J Gastrointest Surg       Date:  2011-06-14       Impact factor: 3.452

Review 3.  Glucagon and type 2 diabetes: the return of the alpha cell.

Authors:  Asger Lund; Jonatan I Bagger; Mikkel Christensen; Filip K Knop; Tina Vilsbøll
Journal:  Curr Diab Rep       Date:  2014-12       Impact factor: 4.810

4.  Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin.

Authors:  V A Gault; F P M O'Harte; P Harriott; M H Mooney; B D Green; P R Flatt
Journal:  Diabetologia       Date:  2003-02-12       Impact factor: 10.122

5.  The effects of glucose-dependent insulinotropic polypeptide infused at physiological concentrations in normal subjects and type 2 (non-insulin-dependent) diabetic patients on glucose tolerance and B-cell secretion.

Authors:  I R Jones; D R Owens; A J Moody; S D Luzio; T Morris; T M Hayes
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

6.  Interaction of fat-stimulated gastric inhibitory polypeptide on pancreatic alpha and beta cell function.

Authors:  C A Verdonk; R A Rizza; R L Nelson; V L Go; J E Gerich; F J Service
Journal:  J Clin Invest       Date:  1980-05       Impact factor: 14.808

7.  Gastric inhibitory polypeptide (GIP) hypersecretion in obesity depends on meal size and is not related to hyperinsulinemia.

Authors:  R Ebert; W Creutzfeldt
Journal:  Acta Diabetol Lat       Date:  1989 Jan-Mar

8.  Stimulation of insulin release in isolated rat islets by GIP in physiological concentrations and its relation to islet cyclic AMP content.

Authors:  E G Siegel; W Creutzfeldt
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

Review 9.  Clinical aspects of GIP secretion.

Authors:  B Beck; C Villaume; G Debry
Journal:  Acta Diabetol Lat       Date:  1982 Jan-Mar

10.  Effect of intraduodenal and intravenous triglyceride infusions on plasma gastric inhibitory polypeptide and insulin in fetal and neonatal pigs.

Authors:  C Kühl; P J Hornnes; S L Jensen; K B Lauritsen
Journal:  Diabetologia       Date:  1982-07       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.